Company: FVN
Filing Date: 2025-03-27
Form Type: DRS/A
Source: 0001829126-25-002094
Chunk: 141

Company: Future Vision II Acquisition Corp.
Filing Date: 2025-03-27
Form: DRS/A
Chunk 141
---
 and quarterly financial statements as if it were a company incorporated in the United States. If this were to happen, New VIWO would likely incur substantial costs in fulfilling these additional regulatory requirements and members of New VIWO’s management would likely have to divert time and resources from other responsibilities to ensuring these additional regulatory requirements are fulfilled.

As an exempted company incorporated in the Cayman Islands, New VIWO will be permitted to adopt certain home country practices in relation to corporate governance matters that differ significantly from the Nasdaq listing standards; these practices may afford less protection to shareholders than they would enjoy if New VIWO complied fully with the Nasdaq listing standards.

As a Cayman Islands exempted
company intending to apply to list its securities on Nasdaq, New VIWO will be subject to the Nasdaq corporate governance listing standards.
However, the Nasdaq rules will permit a foreign private issuer like New VIWO to follow the corporate governance practices of New VIWO’s
home country (assuming New VIWO converts to foreign private issuer on the first available determination date). Certain corporate governance
practices in the Cayman Islands, which is New VIWO’s home country, may differ significantly from the Nasdaq corporate governance
listing standards. For instance, New VIWO will not be required to:

| ● | have a majority of the board be independent (although all of the members of the audit committee must be independent under the Exchange Act); |
| ● | have a compensation committee or a nominations or corporate governance committee consisting entirely of independent directors; or            |
| ● | have                                                                                                                                         
 regularly scheduled executive sessions with only independent directors each year.                                                            |
|   | In addition, New VIWO currently                                                                                                              
 does not intend to hold an annual general meeting or annual director elections, which may severely limit shareholders’ ability               
 to influence corporate governance decisions, including changing directors, approving mergers, or amending constitutional documents.          |

VIWO currently follows and New VIWO may continue to follow its home country practices with respect to corporate governance. As a result of New VIWO’s reliance on the “foreign private issuer” exemptions, New VIWO shareholders may be afforded less protection than they otherwise would enjoy under the Nasdaq corporate governance listing standards applicable to U.S. domestic issuers.

<div align='center'>77</div>

Risks Related to the Business Combination and being a Public Company

Going public through a merger rather than an underwritten offering presents risks to unaffiliated investors. Subsequent to our completion of the business combination, we may be required